F.I.R.S.T Trademark

Trademark Overview

On Friday, July 21, 2023, a trademark application was filed for F.I.R.S.T with the United States Patent and Trademark Office. The USPTO has given the F.I.R.S.T trademark a serial number of 98095865. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, July 28, 2025. This trademark is owned by BioInvent International AB. The F.I.R.S.T trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development; pharmaceutical product development; consultancy pertaining to pharmacology; research and development services in the field of antibody technology
f.i.r.s.t

General Information

Serial Number98095865
Word MarkF.I.R.S.T
Filing DateFriday, July 21, 2023
Status680 - APPROVED FOR PUBLICATION
Status DateMonday, July 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkFIRST 1st
Goods and ServicesScientific research and development; pharmaceutical product development; consultancy pertaining to pharmacology; research and development services in the field of antibody technology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 21, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioInvent International AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLund SE-22370
SE

Trademark Events

Event DateEvent Description
Tuesday, July 25, 2023NEW APPLICATION ENTERED
Monday, August 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 26, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, March 26, 2024ASSIGNED TO EXAMINER
Tuesday, March 26, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 26, 2024SUSPENSION LETTER WRITTEN
Tuesday, January 21, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, January 31, 2025SUSPENSION INQUIRY WRITTEN
Wednesday, April 30, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, January 31, 2025INQUIRY TO SUSPENSION E-MAILED
Friday, January 31, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, April 30, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, July 23, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 25, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 25, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, July 28, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 25, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 23, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 23, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

development research services field technology pharmacology antibody consultancy pharmaceutical product